[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335542-105":59,"doc-detail-335542-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","usp36-promotes-colorectal-cancer-progression-through-inhibition-of-p53-signaling-pathway-via-stabilizing-rbm28","USP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28","","Colorectal cancer remains a major cause of cancer mortality, and improving therapeutic strategies requires deeper mechanistic understanding. This study investigates how ubiquitin-proteasome regulation contributes to CRC progression by focusing on the deubiquitinase USP36 and its impact on p53 signaling. USP36 is shown to be upregulated in CRC datasets and to correlate with poorer patient survival. Mechanistically, USP36 stabilizes the RNA-binding protein RBM28 by deubiquitination at K162, which suppresses p53 pathway activation and reveals a USP36-RBM28-p53 axis as a potential therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/usp36-promotes-colorectal-cancer-progression-through-inhibition-of-p53-signaling-pathway-via-stabilizing-rbm28/335542/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/usp36-promotes-colorectal-cancer-progression-through-inhibition-of-p53-signaling-pathway-via-stabilizing-rbm28/335542.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main finding about USP36 in colorectal cancer?","Question",{"text":112,"@type":113},"USP36 is upregulated in colorectal cancer and is associated with unfavorable prognosis in multiple public datasets.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does USP36 affect the p53 signaling pathway?",{"text":117,"@type":113},"USP36 stabilizes RBM28 through deubiquitination at K162, which subsequently inhibits the p53 signaling pathway.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is the USP36-RBM28-p53 axis considered therapeutically promising?",{"text":121,"@type":113},"The study identifies a mechanistic link connecting USP36 activity to suppression of p53 signaling, supporting a targeted therapeutic strategy for CRC.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335542,1790022987,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www.nature.com/onc](www.nature.com/onc Oncogene)[ Oncogene](www.nature.com/onc Oncogene)  \nARTICLE OPEN   \nUSP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28  \nHengjie Xu1,2,3,4,5, Tuo Wang 1,2,3,4,5, Hongxu Nie 1,2,3,4,5, Qingyang Sun 1,2,3,4,5, Chi Jin1,2,3,4, Sheng Yang1,2,3,4, Zhihao Chen1,2,3,4, Xiaowei Wang 1,2,3,4, Junwei Tang 1,2,3,4 ✉, Yifei Feng 1,2,3,4 ✉ and Yueming Sun 1,2,3,4 ✉  \n© The Author(s) 2024  \nINTRODUCTION  \nColorectal cancer (CRC) is prevalent globally and is one of the most common malignancies, ranking second in terms of mortality [1] . Despite the availability of novel treatment options such as neoadjuvant chemoradiotherapy and immunotherapy, patients with colorectal cancer (CRC) continue to face poor prognoses [2, 3] . Therefore, more comprehensive studies are needed to elucidate the mechanisms underlying the development of CRC.  \nThe ubiquitin-proteasome system, a crucial post-translational protein modiﬁcation in eukaryotic cells, is responsible for mediating the degradation of proteins through ubiquitination [4, 5] . Accumulating evidence indicated that dysregulation of ubiquitination is associated with multiple processes including proliferation and metastasis [6–9] . The ubiquitination process primarily involves three key enzymes: E1, E2, and E3 ubiquitin ligase, attaching ubiquitin to target proteins [10] . Deubiquitylating enzymes (DUBs), as essential regulators, are responsible for reversing the ubiquitination process by cleaving ubiquitin from target proteins and counteracting E3 ubiquitin ligases [11, 12] . Up to now, nearly 100 DUBs have been categorized into six families: USPs, UCHs, OTUs, JAMM, MCPIPs, and MINDYs [13] . Ubiquitinspeciﬁc protease 36 (USP36), belonging to the deubiquitinase family, exhibits dysregulation across diverse cancers and mediates the deubiquitination of multiple substrate proteins. For example, USP36 interacted with and stabilized ALKBH5 in glioblastoma [14] . USP36 facilitated the Hippo signaling pathway in gastric cancer (GC) and esophageal squamous carcinoma (ESCC) through the stabilization of TAZ and YAP [15, 16] . Furthermore, USP36  \npromoted Hepatocellular carcinoma (HCC) progression by antagonizing the E3 ubiquitin ligase MDM2 [17] . However, further exploration is needed to elucidate the molecular mechanisms of USP36 in CRC.  \nAs a transcription factor, p53 is pivotal in tumor prevention and involved in various cellular processes [18], including cell proliferation, apoptosis, senescence, metastasis, and metabolism [19, 20] . The primary mechanism by which p53 functions as a tumor suppressor is to regulate the transcription of genes such as CDKN1A, BAX, and FAS, a series of target genes associated with tumor progression and metastasis [21, 22] . However, as the most important tumor suppressor, p53-based treatments are restricted by the lack of typical drug-targeting features [23]. Thus, exploring negative regulators of p53 may provide new therapeutic approaches for cancer treatment.  \nRBM28, an RNA-binding protein, is a part of spliceosomal small nuclear ribonucleoproteins (snRNPs) and contributes to thenucleolar stress response. Moreover, RBM28 has been reported to exhibit notable enrichment in the platelet RNAs of lung cancer [24] and is associated with splicing alterations in head and necksquamous cell carcinoma and lung squamous cell carcinoma [25] . Most importantly, RBM28 could interact with the DNA-binding domain of p53 to inhibit p53 transcriptional activity [26] . However, the roles and regulatory mechanisms involving RBM28 in CRC remain incompletely characterized.  \nIn our study, we veriﬁed the upregulation of USP36 in colorectal cancer and its association with unfavorable prognosis. Mechanically, we identiﬁed that USP36 stabilizes RBM28 through  \n1Department of General Surgery, The First Afﬁliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of China. 2The ","cbCaid55OawZLVYv","https://ap.wps.com/l/cbCaid55OawZLVYv","pdf",10252221,14,"English","# Introduction\n## Ubiquitin-proteasome system and deubiquitylating enzymes\n## USP36 roles across cancers\n## p53 tumor suppressor and negative regulators\n## RBM28 as a p53 inhibitor\n# Results\n## USP36 inhibits p53 signaling by impairing p53 transcriptional activity\n## USP36 expression in CRC and survival correlation\n## USP36 linkage to p53 signaling via GSEA","[{\"question\":\"What is the main finding about USP36 in colorectal cancer?\",\"answer\":\"USP36 is upregulated in colorectal cancer and is associated with unfavorable prognosis in multiple public datasets.\"},{\"question\":\"How does USP36 affect the p53 signaling pathway?\",\"answer\":\"USP36 stabilizes RBM28 through deubiquitination at K162, which subsequently inhibits the p53 signaling pathway.\"},{\"question\":\"Why is the USP36-RBM28-p53 axis considered therapeutically promising?\",\"answer\":\"The study identifies a mechanistic link connecting USP36 activity to suppression of p53 signaling, supporting a targeted therapeutic strategy for CRC.\"}]","USP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28 | PDF",1790011379,35]